Product image of Isotretinoïne Doc (Isotretinoin) supplied by GNH India

Isotretinoïne Doc

Active Ingredient:
Isotretinoin
Origin:
EU

Isotretinoïne Doc (Isotretinoin)

Isotretinoin, the active ingredient in Isotretinoïne Doc, is a retinoid presented as an oral formulation for oral use. It is indicated for the treatment of severe nodular acne and recalcitrant acne vulgaris in patients who have not responded to conventional therapies. The medication works by targeting the skin's sebaceous glands to reduce oil production and inflammation.

GNH India supplies Isotretinoïne Doc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Doc Generici S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Isotretinoin is a systemic retinoid used in the management of severe acne conditions.
  • Severe nodular acne: reduces lesion count and prevents scarring.
  • Recalcitrant acne vulgaris: achieves clearance of persistent inflammatory lesions.

How It Works

  • Isotretinoin binds to nuclear retinoic acid receptors (RARs) in skin cells, leading to decreased sebaceous gland size and reduced sebum production. It also normalizes follicular keratinization and exerts anti‑inflammatory effects, thereby limiting the proliferation of Propionibacterium acnes and reducing acne lesion formation.

Side Effects

Isotretinoin may cause a range of adverse reactions. Patients should be monitored regularly for both common and serious events.

Common Side Effects

  • Dry skin and mucous membranes
  • Cheilitis (cracked lips)
  • Dry eyes or irritation
  • Nasal dryness leading to epistaxis
  • Photosensitivity to sunlight
  • Elevated triglyceride levels

Serious or Rare Side Effects

  • Severe liver enzyme elevation
  • Pancreatitis
  • Depression, suicidal ideation, or mood changes
  • Teratogenic effects causing fetal malformations
  • Pseudotumor cerebri (increased intracranial pressure)
  • Severe hypervitaminosis A manifestations

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient history and conduct baseline laboratory tests.

  • Pregnancy contraindication: avoid use in pregnant women due to high teratogenic risk.
  • Contraception requirement: effective birth control must be used during treatment and for one month after cessation.
  • Liver function monitoring: perform periodic liver enzyme tests.
  • Lipid profile monitoring: check serum triglycerides regularly.
  • Avoid concurrent vitamin A supplementation: may increase toxicity.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Isotretinoin can interact with several medications, requiring careful management.

Major Interactions (Avoid)

  • Tetracycline antibiotics: increased risk of intracranial hypertension.
  • Vitamin A supplements: additive risk of hypervitaminosis A.

Moderate Interactions (Monitor Closely)

  • Systemic corticosteroids: may reduce isotretinoin efficacy.
  • Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may lower drug levels.
  • Azole antifungals (e.g., ketoconazole): may raise isotretinoin concentrations.

Frequently Asked Questions

Isotretinoïne Doc contains isotretinoin, which is prescribed for severe nodular acne and recalcitrant acne vulgaris that have not improved with standard topical or oral antibiotics. It is typically reserved for patients requiring systemic therapy to achieve significant lesion reduction and prevent scarring.

Isotretinoin binds to nuclear retinoic acid receptors in skin cells, leading to reduced size and activity of sebaceous glands, lower sebum output, normalization of follicular keratinization, and anti‑inflammatory effects. These actions collectively limit bacterial growth and prevent formation of new acne lesions.

The specific dose of Isotretinoïne Doc is individualized by the prescribing clinician based on the patient’s weight, severity of acne, and laboratory results. Dosage regimens are not standardized in public information and should follow the prescriber’s instructions.

Isotretinoïne Doc is classified as pregnancy category X because it is highly teratogenic. It must not be used by pregnant women or women who may become pregnant. Breastfeeding is also contraindicated, as the drug can be excreted in milk and affect the infant.

To order Isotretinoïne Doc, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with oral antibiotics, isotretinoin offers a disease‑modifying effect that can lead to long‑term remission, whereas antibiotics mainly provide temporary bacterial suppression. Unlike other retinoids such as acitretin, isotretinoin is specifically approved for severe acne and has a more favorable efficacy profile for this indication, though both share similar safety considerations.

Isotretinoïne Doc should be stored below 25 °C in a dry environment. Keep the product in its original packaging to protect it from moisture and light, and ensure the container is tightly closed when not in use.

Isotretinoïne Doc is taken orally, usually with a meal to improve absorption. The tablets or capsules should be swallowed whole with water and not crushed or chewed. Patients should follow the dosing schedule provided by their healthcare professional.

The most serious risks include severe birth defects if taken during pregnancy, significant liver enzyme elevation, hypertriglyceridemia, pancreatitis, and potential neuropsychiatric effects such as depression or suicidal thoughts. Prompt reporting of any concerning symptoms to a healthcare provider is essential.

Isotretinoïne Doc is contraindicated in pregnant women, women planning pregnancy, and breastfeeding mothers. It should also be avoided in patients with pre‑existing severe liver disease, uncontrolled hyperlipidaemia, or a history of hypersensitivity to isotretinoin or any formulation excipients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Isotretinoin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT